providers-news-2023-pharmacy-glp-1-drugs-11-2023.pdf
Customize your policy alerts
Sign up for all Florida Blue policy alerts
Know when Florida Blue releases new policies or updates existing guidance.
Monitor payer policy activity
Provider bulletin from Florida Blue describing pharmacy coverage and prior authorization requirements for the GLP-1 drug class for commercial and Medicare plans, limiting coverage to FDA‑approved indications for type 2 diabetes and excluding use for weight loss/management.
Commercial GLP‑1 prior authorization criteria were updated to require clinical documentation of type 2 diabetes diagnosis and documentation of prior trial/failure of metformin/metformin combinations or insulin.
Florida Blue clarified that GLP‑1 coverage is limited to FDA‑approved indications for type 2 diabetes and that medications for weight loss/management are excluded.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.